West Pharmaceutical Services, Inc’s recent filing unveils that its VP & Treasurer Witherspoon Charles unloaded Company’s shares for reported $0.22 million on Oct 29 ’24. In the deal valued at $310.40 per share,703 shares were sold. As a result of this transaction, Witherspoon Charles now holds 1,253 shares worth roughly $0.39 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Witherspoon Charles sold 1,029 shares, generating $308,700 in total proceeds. Upon selling the shares at $300.00, the VP & Treasurer now owns 1,478 shares.
Before that, Hofmann Thomas W sold 617 shares. West Pharmaceutical Services, Inc shares valued at $225,773 were divested by the Director at a price of $365.92 per share. As a result of the transaction, Hofmann Thomas W now holds 43,565 shares, worth roughly $13.7 million.
Jefferies upgraded its West Pharmaceutical Services, Inc [WST] rating to a Buy from a a Hold in a research note published on February 07, 2024; the price target was increased to $536 from $323. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid June from “a Neutral” to “a Buy”. Stephens also remained covering WST and has increased its forecast on April 11, 2023 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Deutsche Bank started covering the stock on December 14, 2022. It rated WST as “a Hold”.
Price Performance Review of WST
On Friday, West Pharmaceutical Services, Inc [NYSE:WST] saw its stock fall -6.99% to $314.49. Over the last five days, the stock has lost -2.97%. West Pharmaceutical Services, Inc shares have fallen nearly -10.69% since the year began. Nevertheless, the stocks have fallen -9.10% over the past one year. While a 52-week high of $413.70 was reached on 02/07/24, a 52-week low of $265.00 was recorded on 07/25/24. SMA at 50 days reached $305.97, while 200 days put it at $335.49.
Levels Of Support And Resistance For WST Stock
The 24-hour chart illustrates a support level at 305.79, which if violated will result in even more drops to 297.10. On the upside, there is a resistance level at 330.54. A further resistance level may holdings at 346.59. The Relative Strength Index (RSI) on the 14-day chart is 49.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 9.14, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bearish at 83.35%. Stochastics %K at 62.12% indicates the stock is a holding.
How much short interest is there in West Pharmaceutical Services, Inc?
A steep rise in short interest was recorded in West Pharmaceutical Services, Inc stocks on 2024-10-31, dropping by 11502.0 shares to a total of 1.43 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.44 million shares. There was a decline of -0.8%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 30, 2022 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $250 price target.
